Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

NCT00429962 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Choroidal Neovascularization
Age-Related Macular Degeneration

Interventions

DRUG: intravitreal ranibizumab
DRUG: intravitreal ranibizumab & photodynamic therapy

Sponsor

University Hospital, Basel, Switzerland